{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T06:28:30Z","timestamp":1749796110417,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Foundation Latin Link Nederland"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Yearly, up to 1 million patients worldwide suffer from cutaneous leishmaniasis (CL). In Ecuador, CL affects an estimated 5000 patients annually. CL leads to reduced Health Related Quality of Life (HRQL) as a result of stigma in the Asian and Mediterranean contexts, but research is lacking for Ecuador. The objective of this study was to explore the influence of CL suspected lesions on the quality of life of patients in the Pacific and Amazon regions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients for this study were included in the Amazonian Napo, Pastaza, and Morona Santiago provinces and the Pacific region of the Pichincha province. Participating centers offered free of charge CL treatment. All patients suspected of CL and referred for a cutaneous smear slide microscopy examination were eligible. This study applied the Skindex-29 questionnaire, a generic tool to measure HRQL in patients with skin diseases. All statistical analysis was done with SPSS Statistics version 28.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The skindex-29 questionnaire was completed adequately by 279 patients who were included in this study. All patient groups from the Amazon scored significantly (P\u2009&lt;\u20090.01) higher (indicating worse HRQL) on all the dimensions of the Skindex-29 questionnaire than Mestizo patients from the Pacific region. The percentage of patients with health seeking delay of less than a month was significantly (P\u2009&lt;\u20090.01) lower in the Amazon region (38%) than in the Pacific (66%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present study revealed that the influence of suspected CL lesions on the HRQL of patients in the Ecuadorian Amazon and Pacific depends on the geographic region more than on patient characteristics such as gender, age, number of lesions, lesion type, location of lesions, health seeking delay, or posterior confirmation of the <jats:italic>Leishmania<\/jats:italic> parasite. The health seeking delay in the Amazon might result from a lack of health infrastructure or related stigma. Together, the impaired HRQL and prolonged health seeking delay in the Amazon lead to prolonged suffering and a worse health outcome. Determinants of health seeking delay should be clarified in future studies and CL case finding must be improved. Moreover, HRQL analysis in other CL endemic regions could improve local health management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07733-4","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T20:38:38Z","timestamp":1664051918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Quality of life of cutaneous leishmaniasis suspected patients in the Ecuadorian Pacific and Amazon regions: a cross sectional study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7116-1341","authenticated-orcid":false,"given":"Jacob Machiel","family":"Bezemer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Calvopi\u00f1a","family":"Hinojosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Estefania Corral","family":"Zabala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Ortega","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica Cristina Vargas","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk Dirk Frederik Herman","family":"Schallig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry John Christiaan","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,24]]},"reference":[{"issue":"5","key":"7733_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. 2012;7(5): e35671.","journal-title":"PLoS ONE"},{"key":"7733_CR2","unstructured":"Saeedi M. Leishmaniasis Geneva: World Health Organization; 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis. Accessed: 25 January 2022."},{"key":"7733_CR3","volume":"219","author":"AR Henr\u00edquez-Trujillo","year":"2019","unstructured":"Henr\u00edquez-Trujillo AR, Coral-Almeida M, Hinojosa MC. The burden of cutaneous and mucocutaneous leishmaniasis in Ecuador (2014\u20132018), a national registry-based study. bioRxiv. 2019;219: 751446.","journal-title":"bioRxiv"},{"issue":"7","key":"7733_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1590\/S0074-02762004000700001","volume":"99","author":"M Calvopina","year":"2004","unstructured":"Calvopina M, Armijos RX, Hashiguchi Y. Epidemiology of leishmaniasis in Ecuador: current status of knowledge\u2014a review. Mem Inst Oswaldo Cruz. 2004;99(7):663\u201372.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"7733_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12889-018-5260-9","volume":"18","author":"I Bennis","year":"2018","unstructured":"Bennis I, De Brouwere V, Belrhiti Z, Sahibi H, Boelaert M. Psychosocial burden of localised cutaneous Leishmaniasis: a scoping review. BMC Public Health. 2018;18(1):358.","journal-title":"BMC Public Health"},{"key":"7733_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.socscimed.2015.12.044","volume":"151","author":"S Ramdas","year":"2016","unstructured":"Ramdas S, van der Geest S, Schallig HD. Nuancing stigma through ethnography: the case of cutaneous leishmaniasis in Suriname. Soc Sci Med. 2016;151:139\u201346.","journal-title":"Soc Sci Med"},{"key":"7733_CR7","doi-asserted-by":"publisher","DOI":"10.1017\/gmh.2021.18","volume":"8","author":"R van Wijk","year":"2021","unstructured":"van Wijk R, van Selm L, Barbosa MC, van Brakel WH, Waltz M, Philipp PK. Psychosocial burden of neglected tropical diseases in eastern Colombia: an explorative qualitative study in persons affected by leprosy, cutaneous leishmaniasis and Chagas disease. Glob Ment Health (Camb). 2021;8: e21.","journal-title":"Glob Ment Health (Camb)"},{"issue":"2","key":"7733_CR8","first-page":"1994","volume":"28","author":"MM Weigel","year":"1994","unstructured":"Weigel MM, Armijos RX, Racines R, Zurita C, Izurieta R, Herrera E, et al. Cutaneous leishmaniasis in subtropical Ecuador: popular perceptions, knowledge, and treatment. Bull Pan Am Health Organ (PAHO). 1994;28(2):1994.","journal-title":"Bull Pan Am Health Organ (PAHO)"},{"key":"7733_CR9","unstructured":"Siguencia Ibadango SK. Discriminaci\u00f3n salarial por etnia en el per\u00edodo 2010\u20132017 en el Ecuador: PUCE-Quito; 2018."},{"issue":"1","key":"7733_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1525\/jlca.2003.8.1.52","volume":"8","author":"NE Whitten Jr","year":"2003","unstructured":"Whitten NE Jr. Symbolic inversion, the topology of El Mestizaje, and the spaces of Las Razas in Ecuador. J Lat Am Anthropol. 2003;8(1):52\u201385.","journal-title":"J Lat Am Anthropol"},{"issue":"1","key":"7733_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-021-03234-0","volume":"21","author":"E Bautista-Valarezo","year":"2021","unstructured":"Bautista-Valarezo E, Duque V, Verhoeven V, Mejia Chicaiza J, Hendrickx K, Maldonado-Rengel R, et al. Perceptions of Ecuadorian indigenous healers on their relationship with the formal health care system: barriers and opportunities. BMC Complement Med Ther. 2021;21(1):1\u201310.","journal-title":"BMC Complement Med Ther"},{"key":"7733_CR12","unstructured":"Lopez G. POBLACI\u00d3N QUE SE AUTOIDENTIFIC\u00d3 IND\u00cdGENA, SEG\u00daN PROVINCIA DE EMPADRONAMIENTO, NACIONALIDAD O PUEBLO IND\u00cdGENA AL QUE PERTENECE Y SEXO Quito: INEC; 2010 https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwi6per4kJv2AhVCNewKHUBlBewQFnoECBMQAQ&url=https%3A%2F%2Fwww.ecuadorencifras.gob.ec%2Fwp-content%2Fplugins%2Fdownload-monitor%2Fdownload.php%3Fid%3D339%26force%3D0&usg=AOvVaw1sZMlqB_kh_8O316Yy4T8I. Accessed: 25 February 2022."},{"key":"7733_CR13","unstructured":"CONFENIAE. Nacionalidades Puyo: CONFENIAE; 2022 https:\/\/confeniae.net\/nacionalidades. Accessed: 24 February 2022."},{"issue":"10","key":"7733_CR14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1371\/journal.pntd.0008759","volume":"14","author":"R Hu","year":"2020","unstructured":"Hu R, Ramdas S, Nieuwkerk P, Reis R, Lai AFRFM, Devries HJC, et al. Body location of \u201cNew World\u201d cutaneous leishmaniasis lesions and its impact on the quality of life of patients in Suriname. PLoS Negl Trop Dis. 2020;14(10):759.","journal-title":"PLoS Negl Trop Dis"},{"key":"7733_CR15","first-page":"82","volume":"6","author":"M Calvopi\u00f1a","year":"2005","unstructured":"Calvopi\u00f1a M, Angel G, Armijos R, Gomez E, Mimori T, Cooper P, et al. Clinical features of mucocutaneous leishmaniasis in the Amazonian region of Ecuador. Res Rep Ser. 2005;6:82\u20139.","journal-title":"Res Rep Ser"},{"issue":"3","key":"7733_CR16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.31243\/mdc.uta.v5i3.1189.2021","volume":"5","author":"CJT Espin","year":"2021","unstructured":"Espin CJT, Procel MC. Leishmaniasis en el Ecuador: revisi\u00f3n bibliogr\u00e1fica. Mediciencias UTA. 2021;5(3):2\u201311.","journal-title":"Mediciencias UTA"},{"issue":"11","key":"7733_CR17","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","volume":"133","author":"MM Chren","year":"1997","unstructured":"Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433\u201340.","journal-title":"Arch Dermatol"},{"issue":"2","key":"7733_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.det.2011.11.003","volume":"30","author":"MM Chren","year":"2012","unstructured":"Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30(2):231\u20136.","journal-title":"Dermatol Clin"},{"issue":"4","key":"7733_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-4632.2007.03008.x","volume":"46","author":"AE Aksu","year":"2007","unstructured":"Aksu AE, Urer MS, Sabuncu I, Saracoglu ZN, Chren MM. Turkish version of Skindex-29. Int J Dermatol. 2007;46(4):350\u20135.","journal-title":"Int J Dermatol"},{"key":"7733_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12955-014-0190-4","volume":"12","author":"Z He","year":"2014","unstructured":"He Z, Lu C, Chren MM, Zhang Z, Li Y, Ni X, et al. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16. Health Qual Life Outcomes. 2014;12:190.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"7733_CR21","first-page":"34","volume":"81","author":"A Zghal","year":"2003","unstructured":"Zghal A, Zeglaoui F, Kallel L, Karmous R, Ben Ammar H, Labbane R, et al. Quality of life in dermatology: Tunisian version of the Skindex-29. Tunis Med. 2003;81(1):34\u20137.","journal-title":"Tunis Med"},{"issue":"4","key":"7733_CR22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1590\/abd1806-4841.20142453","volume":"89","author":"HR Paula","year":"2014","unstructured":"Paula HR, Haddad A, Weiss MA, Dini GM, Ferreira LM. Translation, cultural adaptation, and validation of the American Skindex-29 quality of life index. An Bras Dermatol. 2014;89(4):600\u20137.","journal-title":"An Bras Dermatol"},{"issue":"2","key":"7733_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/1203475417745826","volume":"22","author":"A Alavi","year":"2018","unstructured":"Alavi A, Farzanfar D, Lee RK, Almutairi D. The contribution of malodour in quality of life of patients with hidradenitis suppurativa. J Cutan Med Surg. 2018;22(2):166\u201374.","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"7733_CR24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/bjd.17742","volume":"181","author":"D Vasquez","year":"2019","unstructured":"Vasquez D, Aguirre DC, Sanclemente G. Construct validity and responsiveness of the Colombian version of Skindex-29. Br J Dermatol. 2019;181(4):770\u20137.","journal-title":"Br J Dermatol"},{"key":"7733_CR25","unstructured":"CODENPE. Modulo 3: Interculturalidad. Quito: CODENPE; 2011."},{"key":"7733_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.actatropica.2016.11.039","volume":"166","author":"Y Hashiguchi","year":"2017","unstructured":"Hashiguchi Y, Velez LN, Villegas NV, Mimori T, Gomez EAL, Kato H. Leishmaniases in Ecuador: comprehensive review and current status. Acta Trop. 2017;166:299\u2013315.","journal-title":"Acta Trop"},{"issue":"7","key":"7733_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004844","volume":"10","author":"H Kato","year":"2016","unstructured":"Kato H, Gomez EA, Martini-Robles L, Muzzio J, Velez L, Calvopi\u00f1a M, et al. Geographic distribution of Leishmania species in Ecuador based on the cytochrome B gene sequence analysis. PLoS Negl Trop Dis. 2016;10(7): e0004844.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"7733_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.5114\/pdia.2014.40983","volume":"32","author":"MT Szewczyk","year":"2015","unstructured":"Szewczyk MT, Mo\u015bcicka P, Jawie\u0144 A, Cwajda-Bia\u0142asik J, Cierzniakowska K, \u015alusarz R, et al. Quality of life in patients with leg ulcers or skin lesions\u2014a pilot study. Postepy Dermatol Alergol. 2015;32(6):465\u20139.","journal-title":"Postepy Dermatol Alergol"},{"key":"7733_CR29","unstructured":"IBM. SPSS Statistics for Windows. Version 28.0. Armonk. New York: IBM; 2021."},{"key":"7733_CR30","unstructured":"Vargas V, Bezemer J, Calvopina M, Schallig H, Ortega F, Salazar N, et al. Perceptions of American tegumentary leishmaniasis in Ecuador: questioning the visuality of aesthetic stigma. 2022."},{"issue":"8","key":"7733_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009651","volume":"15","author":"Y Dharmawan","year":"2021","unstructured":"Dharmawan Y, Fuady A, Korfage I, Richardus JH. Individual and community factors determining delayed leprosy case detection: a systematic review. PLoS Negl Trop Dis. 2021;15(8): e0009651.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"7733_CR32","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/0035-9203(72)90085-5","volume":"66","author":"J Shaw","year":"1972","unstructured":"Shaw J, Lainson R, Ward R. Leishmaniasis in Brazil: VII. Further observations on the feeding habitats of Lutzomyia flaviscutellata (Mangabeira) with particular reference to its biting habits at different heights. Trans R Soc Trop Med Hygiene. 1972;66(5):718\u201323.","journal-title":"Trans R Soc Trop Med Hygiene."},{"key":"7733_CR33","volume-title":"Prevalencia de leishmaniasis en el area II de Pastaza, asociados a factores de riesgo que influyen en el desarrollo de la enfermedad","author":"E Conteron","year":"2015","unstructured":"Conteron E. Prevalencia de leishmaniasis en el area II de Pastaza, asociados a factores de riesgo que influyen en el desarrollo de la enfermedad. Ambato: Universidad Tecnica de Ambato; 2015."},{"issue":"2","key":"7733_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1046\/j.1365-3156.1997.d01-236.x","volume":"2","author":"R Armijos","year":"1997","unstructured":"Armijos R, Weigel M, Izurieta R, Racines J, Zurita C, Herrera W, et al. The epidemiology of cutaneous leishmaniasis in subtropical Ecuador. Tropical Med Int Health. 1997;2(2):140\u201352.","journal-title":"Tropical Med Int Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07733-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07733-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07733-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T20:40:52Z","timestamp":1664052052000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07733-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7733"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07733-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2022,9,24]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethical committee of the \u2018Universidad Internacional del Ecuador\u2019, permission number UIDE-FCM-EDM-COM-18-0069, and by the Ecuadorian Ministry of Health, permission number MSPCURI000284-3, prior to its initiation. All participants or their legal representative gave written informed consent prior to participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"748"}}